Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Sunesis Pharmaceuticals Inc patents


Recent patent applications related to Sunesis Pharmaceuticals Inc. Sunesis Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Sunesis Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Sunesis Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Sunesis Pharmaceuticals Inc-related inventors


Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer

Methods of treating, preventing or managing cancer, including certain leukemias are disclosed. The methods encompass the administration of enantiomerically pure (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid. ... Sunesis Pharmaceuticals Inc

Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disorders

Methods of treating, preventing or managing antecedent hematologic disorders, such as myelodysplastic syndrome, including chronic myelomonocytic leukemia are disclosed. The methods encompass the administration of sns-595. ... Sunesis Pharmaceuticals Inc

Stable sns-595 compositions and methods of preparation

Methods of preparing substantially pure sns-595 substance are disclosed. Also provided are compositions comprising sns-595 substance that are substantially pure and essentially free of visible particles.. ... Sunesis Pharmaceuticals Inc

Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activity

Methods of using sns-595 for treatment of a subject having cancer with brca2 mutation are described. In certain embodiments, the methods comprise administering a therapeutically effective amount of sns-595 to a subject in need thereof.. ... Sunesis Pharmaceuticals Inc

Compounds useful as raf kinase inhibitors

The present invention provides compounds useful as inhibitors of raf protein kinase. The present invention also provides compositions thereof, and methods of treating raf-mediated diseases.. ... Sunesis Pharmaceuticals Inc

Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of certain hematologic disorders

Methods of treating, preventing or managing hematologic disorders, such as leukemia are disclosed. The methods encompass the administration of sns-595. ... Sunesis Pharmaceuticals Inc

Inhibitors of bruton's tyrosine kinase

The present invention provides a compound, solid forms, and compositions thereof, which are useful as inhibitors of bruton's tyrosine kinase and which exhibit desirable characteristics for the same. The present invention also provides methods of making provided compound and solid forms.. ... Sunesis Pharmaceuticals Inc

Compounds and compositions for treatment of cancer

Compounds and compositions for treating, preventing or managing cancer are disclosed. The compositions provided herein comprise sns-595 and n-desmethyl-sns-595. ... Sunesis Pharmaceuticals Inc

Method of preparing (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid

Methods of preparing (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid are disclosed. Also provided are pharmaceutical compositions comprising (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid, and methods of treatment using such compositions.. ... Sunesis Pharmaceuticals Inc

Heterocyclic tyrosine kinase inhibitors

The present invention provides compounds useful as inhibitors of tec family kinases, compositions thereof, and methods of using the same.. . ... Sunesis Pharmaceuticals Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Sunesis Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Sunesis Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###